CNTO 328
All > Medicine > Cancer
- A chimeric (made from human and mouse proteins) monoclonal antibody being studied in the treatment of advanced kidney cancer and other types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. CNTO 328 works by blocking inflammation and tumor growth. Also called anti-IL-6 chimeric monoclonal antibody and cCLB8.
National Cancer Institute - Cite This Source - This Definition - 3F8, A33, alemtuzumab, AMG 162, apolizumab, BB-10901, Campath-1H, CC-49, cCLB8, denosumab, edrecolomab, epitope, galiximab, GC1008, Hu3S193, HuAFP31, HuHMFG1, HuLuc63, lexatumumab, M200, MDX-060, MORAb-009, muJ591, muromonab-CD3, oregovomab, OvaRex, pertuzumab, pM-81, Prost 30, R1507, radioimmunodiagnostics, radioimmunotherapeutics, RAV12, volociximab